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Insulin promotes vascular smooth muscle cell proliferation and apoptosis via 
differential regulation of tumor necrosis factor‐related apoptosis‐inducing ligand  
 ABSTRACT 
Background: Insulin regulates glucose homeostasis but can also promote vascular smooth 
muscle (VSMC) proliferation, important in atherogenesis. Recently, we showed that tumor 
necrosis factor‐related apoptosis‐inducing ligand (TRAIL) stimulates intimal thickening via 
accelerated growth of VSMCs. The aim of the present study was to determine whether 
insulin‐induced effects on VSMCs occur via TRAIL. Methods: Expression of TRAIL and 
TRAIL receptor in response to insulin and glucose was determined by polymerase chain 
reaction. Transcriptional activity was assessed using wild‐type and site‐specific mutations of 
the TRAIL promoter. Chromatin immunoprecipitation studies were performed. VSMC 
proliferation and apoptosis was measured. Results: Insulin and glucose exposure to VSMC 
for 24 h stimulated TRAIL mRNA expression. This was also evident at the transcriptional 
level. Both insulin‐ and glucose‐inducible TRAIL transcriptional activity was blocked by 
dominant‐negative specificity protein‐1 (Sp1) overexpression. There are five functional Sp1‐
binding elements (Sp1‐1, Sp1‐2, Sp‐5/6 and Sp1‐7) on the TRAIL promoter. Insulin required 
the Sp1‐1 and Sp1‐2 sites, but glucose needed all Sp1‐binding sites to induce transcription. 
Furthermore, insulin (but not glucose) was able to promote VSMC proliferation over time, 
associated with increased decoy receptor‐2 (DcR2) expression. In contrast, chronic 5‐day 
exposure of VSMC to 1 µg/mL insulin repressed TRAIL and DcR2 expression, and reduced 
Sp1 enrichment on the TRAIL promoter. This was associated with increased cell death. 
Conclusions: The findings of the present study provide a new mechanistic insight into how 
TRAIL is regulated by insulin. This may have significant implications at different stages of 
diabetes‐associated cardiovascular disease. Thus, TRAIL may offer a novel therapeutic 
solution to combat insulin‐induced vascular pathologies.  
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